Does GLP enhance the quality of toxicological evidence for regulatory decisions?
暂无分享,去创建一个
Richard A. Becker | Keith Solomon | Christopher J. Borgert | L. McCarty | C. Borgert | R. Becker | K. Solomon | Kun Don Yi | Terry F. Quill | G. J. Van Der Kraak | Glen Van Der Kraak | Lynn S. McCarty | Raphael J. Witorsch | Betsy D. Carlton | Mark Hanson | Patricia L. Kwiatkowski | Mary Sue Marty | Kun Don Yi | P. Kwiatkowski | R. Witorsch | M. Sue Marty | M. Hanson
[1] Koji Arizono,et al. Why Public Health Agencies Cannot Depend on Good Laboratory Practices as a Criterion for Selecting Data: The Case of Bisphenol A , 2008, Environmental health perspectives.
[2] Marlene Ågerstrand,et al. CRED: Criteria for reporting and evaluating ecotoxicity data , 2016, Environmental toxicology and chemistry.
[3] J. McLachlan,et al. Synergistic effect of environmental estrogens: report withdrawn. , 1997, Science.
[4] K. Munkittrick,et al. Statistical reporting deficiencies in environmental toxicology , 2013, Environmental toxicology and chemistry.
[5] Marcia McNutt,et al. Journals unite for reproducibility , 2014, Science.
[6] M. Fortelius,et al. Molar Tooth Diversity, Disparity, and Ecology in Cenozoic Ungulate Radiations , 1996, Science.
[7] Journals unite for reproducibility , 2014, Nature.
[8] K M Crofton,et al. Evaluation of the ToxRTool's ability to rate the reliability of toxicological data for human health hazard assessments. , 2015, Regulatory toxicology and pharmacology : RTP.
[9] Taisen Iguchi,et al. A path forward in the debate over health impacts of endocrine disrupting chemicals , 2014, Environmental Health.
[10] R. Tyl. Basic Exploratory Research versus Guideline-Compliant Studies Used for Hazard Evaluation and Risk Assessment: Bisphenol A as a Case Study , 2009, Environmental health perspectives.
[11] Thomas Hartung,et al. "ToxRTool", a new tool to assess the reliability of toxicological data. , 2009, Toxicology letters.
[12] R B Conolly,et al. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments. , 1995, Cancer letters.
[13] Steven F. Arnold,et al. Synergistic Activation of Estrogen Receptor with Combinations of Environmental Chemicals , 1996, Science.
[14] P M Schlosser,et al. Determining modes of action for biologically based risk assessments. , 1999, Regulatory toxicology and pharmacology : RTP.
[15] A. Bayraktar,et al. OECD (Organisation for Economic Cooperation and Development) and environment. , 2010 .
[16] Christopher J. Borgert,et al. Information Quality in Regulatory Decision Making: Peer Review versus Good Laboratory Practice , 2012, Environmental health perspectives.
[17] G. B. Gori,et al. Principles of Pharmacology and Toxicology Also Govern Effects of Chemicals on the Endocrine System. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.
[18] Alan R. Boobis,et al. IPCS Framework for Analyzing the Relevance of a Noncancer Mode of Action for Humans , 2008, Critical reviews in toxicology.
[19] Anne M. Baldeshwiler. History of FDA good laboratory practices , 2003 .
[20] F. Prinz,et al. Believe it or not: how much can we rely on published data on potential drug targets? , 2011, Nature Reviews Drug Discovery.
[21] J. Corton,et al. Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPARα) as a case study , 2014, Critical reviews in toxicology.
[22] Laura N Vandenberg,et al. Assessing dose–response relationships for endocrine disrupting chemicals (EDCs): a focus on non-monotonicity , 2015, Environmental Health.
[23] L. McCarty,et al. Can mode of action predict mixture toxicity for risk assessment? , 2004, Toxicology and applied pharmacology.
[24] J. Wiltse,et al. US Environmental Protection Agency's revised guidelines for Carcinogen Risk Assessment: incorporating mode of action data. , 1998, Mutation research.
[25] Claude Emond,et al. Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment , 2015, Environmental Health.
[26] Richard A. Becker,et al. Good Laboratory Practices and Safety Assessments , 2009, Environmental health perspectives.
[27] Richard A Becker,et al. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program. , 2011, Regulatory toxicology and pharmacology : RTP.
[28] Seema K. Schappelle,et al. Enhancing the credibility of decisions based on scientific conclusions: transparency is imperative. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.
[29] Werner Kloas,et al. Effects of Atrazine in Fish, Amphibians, and Reptiles: An Analysis Based on Quantitative Weight of Evidence , 2014, Critical reviews in toxicology.
[30] Bruce Alberts,et al. Making Data Maximally Available , 2011, Science.
[31] Richard A. Becker,et al. A survey of frameworks for best practices in weight-of-evidence analyses , 2013, Critical reviews in toxicology.
[32] M E Meek,et al. New developments in the evolution and application of the WHO/IPCS framework on mode of action/species concordance analysis , 2013, Journal of applied toxicology : JAT.
[33] U. Tillmann,et al. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. , 1997, Regulatory toxicology and pharmacology : RTP.